home / stock / anab / anab quote
Last: | $25.68 |
---|---|
Change Percent: | -0.78% |
Open: | $25.97 |
Close: | $25.68 |
High: | $26.5 |
Low: | $25.168 |
Volume: | 320,769 |
Last Trade Date Time: | 05/07/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$25.68 | $25.97 | $25.68 | $26.5 | $25.168 | 320,769 | 05-07-2024 |
$25.77 | $26.6 | $25.77 | $26.63 | $25.29 | 195,199 | 05-06-2024 |
$26.58 | $26.76 | $26.58 | $27.02 | $25.64 | 332,065 | 05-03-2024 |
$26.34 | $26.26 | $26.34 | $26.74 | $24.75 | 324,822 | 05-02-2024 |
$26.02 | $24.38 | $26.02 | $26.35 | $24.38 | 794,807 | 05-01-2024 |
$24.34 | $21.26 | $24.34 | $24.5 | $21.02 | 1,100,993 | 04-30-2024 |
$21.3 | $21.02 | $21.3 | $22.74 | $21.02 | 719,618 | 04-29-2024 |
$21 | $18.92 | $21 | $21.61 | $18.715 | 649,412 | 04-26-2024 |
$18.87 | $18.87 | $18.87 | $19.3 | $18.49 | 401,012 | 04-25-2024 |
$19.27 | $19.01 | $19.27 | $19.29 | $18.71 | 308,207 | 04-24-2024 |
$19.18 | $19.52 | $19.18 | $20.48 | $19.17 | 387,321 | 04-23-2024 |
$19.66 | $19.93 | $19.66 | $20.265 | $19.6 | 139,714 | 04-22-2024 |
$19.87 | $19.61 | $19.87 | $20.66 | $19.08 | 288,943 | 04-19-2024 |
$19.83 | $21.29 | $19.83 | $21.78 | $19.785 | 363,855 | 04-18-2024 |
$21.47 | $21.27 | $21.47 | $21.56 | $20.83 | 297,067 | 04-17-2024 |
$21.34 | $21.55 | $21.34 | $22.15 | $21.03 | 244,875 | 04-16-2024 |
$21.27 | $22.56 | $21.27 | $23.1 | $21.06 | 267,275 | 04-15-2024 |
$22.71 | $24.89 | $22.71 | $24.94 | $22.53 | 347,661 | 04-12-2024 |
$24.73 | $24.81 | $24.73 | $25.62 | $23.86 | 572,975 | 04-11-2024 |
$22.17 | $21.08 | $22.17 | $22.45 | $20.71 | 349,285 | 04-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Actym Therapeutics Appoints Thomas Smart as CEO PR Newswire BERKELEY, Calif. , April 24, 2024 /PRNewswire/ -- Actym Therapeutics , pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as Chief Executive Off...
2024-04-16 09:00:05 ET David Risinger from Leerink Partners issued a price target of $47.00 for ANAB on 2024-04-16 07:27:00. The adjusted price target was set to $47.00. At the time of the announcement, ANAB was trading at $21.27. The overall price target consensus is at...
2024-04-12 19:00:50 ET Many stocks were wobbly over the past few trading days, but we can't say that about biotech AnaptysBio (NASDAQ: ANAB) . The company's shares closed the week almost 8% higher in price, according to data compiled by S&P Global Market Intelligence , large...